T cell apoptosis signaling biomarker of PD-1 engagement in cancer patients

被引：0
|
作者：
Zhao, Wei [1 ]
Dong, Haidong [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-2552
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2552
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PD-1 Tumor Suppressor Signaling in T Cell Lymphomas
    Wartewig, Tim
    Ruland, Juergen
    TRENDS IN IMMUNOLOGY, 2019, 40 (05) : 403 - 414
  • [2] Intracellular Signaling triggered by engagement of PD-1 by PD-L1
    Bu, Xia
    Bu, Melissa
    Hua, Ping
    Zhu, Baogong
    Sharpe, Arlene H.
    Freeman, Gordon J.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [3] Global phosphoproteomic analysis of PD-1 signaling reveals T cell subset specific PD-1 functions
    Tocheva, Anna S.
    Peled, Michael
    Nayak, Shruti
    Philips, Elliot A.
    Ueberheide, Beatrix
    Mor, Adam
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [4] Effects of PD-1 signaling on the molecular control of T cell expansion
    Patsoukis, Nikolaos
    Brown, Julia
    Petkova, Victoria
    Liu, Fang
    Li, Lequn
    Boussiotis, Vassiliki
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [5] Functional T cell diversity drives differences in PD-1 signaling
    Tocheva, Anna S.
    Selvan, Myvizhi
    Gumus, Zeynep
    Mor, Adam
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 62 - 62
  • [6] PD-1 signaling in primary T cells
    Riley, James L.
    IMMUNOLOGICAL REVIEWS, 2009, 229 : 114 - 125
  • [7] PD-1/PD-L1 signaling in JIA synovial regulatory T cell function
    Sytze de Roock
    Genoveva Keustermans
    Chantal L Duurland
    Ellen JM Wehrens
    Femke van Wijk
    Berent J Prakken
    Pediatric Rheumatology, 9 (Suppl 1)
  • [8] Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation
    Kuipers, Harmjan
    Muskens, Femke
    Willart, Monique
    Hijdra, Danielle
    van Assema, Friso B. J.
    Coyle, Anthony J.
    Hoogsteden, Henk C.
    Lambrecht, Bart N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (09) : 2472 - 2482
  • [9] The T-cell repertoire as a biomarker for response to anti PD-1 immunotherapy.
    Philip, Hagit
    Snir, Tom
    Gordin, Miri
    Wigelman, Yoav
    Zilberberg, Alona
    Efroni, Sol
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 105 - 105
  • [10] Biomarker evaluation for PD-1 targeted therapies in non-small cell lung cancer (NSCLC) patients
    Kamphorst, Alice O.
    Pillai, Rathi N.
    Yang, Shu
    Akondy, Rama
    Koenig, Lydia
    Yu, Ke
    McCausland, Megan
    Sica, Gabriel
    Khuri, Fadlo R.
    Owonikoko, Taofeek K.
    Ramalingam, Suresh S.
    Ahmed, Rafi
    CANCER RESEARCH, 2015, 75
12345